DNA profiling and in vitro cytotoxicity studies of tetrazolo[1,5-a]pyrimidine-based copper(II) complexes.
- Published in:
- BioMetals, 2019, v. 32, n. 4, p. 611, doi. 10.1007/s10534-019-00196-2
- By:
- Publication type:
- Article
Works by Mahendiran, Dharmasivam
Results: 14
1
2
In vitro and in vivo anti-proliferative evaluation of bis(4′-(4-tolyl)-2,2′:6′,2″-terpyridine)copper(II) complex against Ehrlich ascites carcinoma tumors.
- Published in:
- Journal of Biological Inorganic Chemistry (JBIC), 2017, v. 22, n. 7, p. 1109, doi. 10.1007/s00775-017-1488-6
- By:
- Publication type:
- Article
3
Synthesis of potent MDA-MB 231 breast cancer drug molecules from single step.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45455-y
- By:
- Publication type:
- Article
4
Synthesis of potent MDA-MB 231 breast cancer drug molecules from single step.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-45455-y
- By:
- Publication type:
- Article
5
Copper(I) complexes of acylthiourea ligands: structural insights and cytotoxic potential.
- Published in:
- Applied Organometallic Chemistry, 2024, v. 38, n. 6, p. 1, doi. 10.1002/aoc.7474
- By:
- Publication type:
- Article
6
Anti‐proliferative potential of copper(I) acylthiourea complexes with triphenylphosphine against breast cancer cells.
- Published in:
- Applied Organometallic Chemistry, 2023, v. 37, n. 6, p. 1, doi. 10.1002/aoc.7087
- By:
- Publication type:
- Article
7
Heteroleptic silver(I), nickel(II), and copper(II) complexes of N<sup>4</sup>‐substituted thiosemicarbazones and ciprofloxacin: Theoretical, in vitro anti‐proliferative, and in silico molecular modeling and pharmacokinetics studies.
- Published in:
- Applied Organometallic Chemistry, 2022, v. 36, n. 8, p. 1, doi. 10.1002/aoc.6782
- By:
- Publication type:
- Article
8
Impact of denticity of chromone/chromene thiosemicarbazones in the ruthenium(II)‐DMSO complexes on their cytotoxicity against breast cancer cells.
- Published in:
- Applied Organometallic Chemistry, 2022, v. 36, n. 7, p. 1, doi. 10.1002/aoc.6750
- By:
- Publication type:
- Article
9
Tetrazolo[1,5-a]pyrimidine-based metal(II) complexes as therapeutic agents: DNA interaction, targeting topoisomerase I and cyclin-dependent kinase studies.
- Published in:
- Inorganic & Nano-Metal Chemistry, 2018, v. 48, n. 12, p. 569, doi. 10.1080/24701556.2019.1571514
- By:
- Publication type:
- Article
10
The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators That Inhibit Their Activity.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 18, p. 6805, doi. 10.3390/ijms21186805
- By:
- Publication type:
- Article
11
In Vitro Antioxidant and Insulin Mimetic Activities of Heteroleptic Oxovanadium(IV) Complexes with Thiosemicarbazones and Naproxen.
- Published in:
- ChemistrySelect, 2020, v. 5, n. 21, p. 6245, doi. 10.1002/slct.202000911
- By:
- Publication type:
- Article
12
Silver(I) metallodrugs of thiosemicarbazones and naproxen: biocompatibility, in vitro anti-proliferative activity and in silico interaction studies with EGFR, VEGFR2 and LOX receptors.
- Published in:
- Toxicology Research, 2020, v. 9, n. 1, p. 28, doi. 10.1093/toxres/tfaa001
- By:
- Publication type:
- Article
13
Silver(I) metallodrugs of thiosemicarbazones and naproxen: biocompatibility, in vitro anti-proliferative activity and in silico interaction studies with EGFR, VEGFR2 and LOX receptors.
- Published in:
- Toxicology Research, 2020, p. 28, doi. 10.1093/toxres/tfaa001
- By:
- Publication type:
- Article
14
Theoretical, in Vitro Antiproliferative, and in Silico Molecular Docking and Pharmacokinetics Studies of Heteroleptic Nickel(II) and Copper(II) Complexes of Thiosemicarbazone‐Based Ligands and Pefloxacin.
- Published in:
- Chemistry & Biodiversity, 2023, v. 20, n. 9, p. 1, doi. 10.1002/cbdv.202300702
- By:
- Publication type:
- Article